Icad inc. Company Profile (NASDAQ:ICAD)

Analyst Ratings

Consensus Ratings for Icad inc. (NASDAQ:ICAD) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Icad inc. (NASDAQ:ICAD)
Show:
DateFirmActionRatingPrice TargetActions
5/10/2015Craig HallumReiterated RatingBuy$9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/27/2014 forward)

Earnings

Earnings History for Icad inc. (NASDAQ:ICAD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/3/2016        
7/27/2016Q2N/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/3/2016Q1($0.14)($0.17)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/1/2016Q4($0.17)($0.14)$7.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2015Q315($0.07)($0.03)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/24/2015Q414$0.04$0.01$13.30 million$13.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2014($0.05)$0.01ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2014Q1($0.15)($0.12)$7.95 million$8.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/19/2014Q4($0.17)($0.41)$8.25 million$9.14 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2013Q313($0.20)($0.11)$8.07 million$8.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/29/2013Q2 2013($0.25)($0.12)$7.56 million$7.71 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/19/2013Q4 2012($0.15)$6.61 million$7.82 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Icad inc. (NASDAQ:ICAD)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.14)($0.14)($0.14)
Q2 20161($0.13)($0.13)($0.13)
Q3 20161($0.09)($0.09)($0.09)
Q4 20161$0.00$0.00$0.00
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Icad inc. (NASDAQ:ICAD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Icad inc. (NASDAQ:ICAD)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
3/4/2016Kenneth M FerryCEOBuy25,000$4.45$111,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/4/2016Kevin C BurnsCFOBuy10,000$4.44$44,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/19/2015Kenneth M FerryCEOSell100,000$10.00$1,000,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/12/2015Somu SubramaniamDirectorSell50,762$9.23$468,533.26View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/10/2015Stacey M StevensSVPSell27,298$10.00$272,980.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/3/2014Stacey M StevensSVPSell2,502$10.00$25,020.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/2/2014Stacey M StevensSVPSell503$10.01$5,035.03View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2014Stacey M StevensSVPSell299$10.00$2,990.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/11/2014Kenneth M FerryCEOSell18,318$11.09$203,146.62View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014Stacey M StevensVPSell10,000$11.31$113,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2014Stacey M StevensVPSell13,333$10.00$133,330.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2014Stacey M StevensVPSell10,000$10.94$109,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/27/2014Kevin C BurnsCFOSell36,439$10.44$380,423.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/25/2014Kenneth M FerryCEOSell40,000$10.71$428,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/20/2014Stacey M StevensVPSell5,000$10.57$52,850.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/19/2014Kenneth M FerryCEOSell20,000$10.06$201,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/26/2013Kenneth M FerryCEOBuy5,000$5.55$27,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/3/2013Kevin C BurnsCFOBuy2,900$5.19$15,051.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/24/2012Kevin C BurnsCFOBuy15,000$2.08$31,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/17/2012Kevin C BurnsCFOBuy28,939$2.90$83,923.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Icad inc. (NASDAQ:ICAD)
DateHeadline
07/27/16 06:07 AMQ2 2016 ICAD Inc Earnings Release - After Market Close -
07/22/16 02:46 AMIcade SA :ICAD-FR: Earnings Analysis: For the six months ended December 31, 2015 : July 22, 2016 -
07/14/16 12:58 PMJuly 14, 2016 iCAD to Host Second Quarter 2016 Financial Results Conference Call on Wednesday, July 27, 2016 - [at noodls] - iCAD to Host Second Quarter 2016 Financial Results Conference Call on Wednesday, July 27, 2016 NASHUA, NH (July 14, 2016)- iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, ...
07/14/16 08:00 AMiCAD to Host Second Quarter 2016 Financial Results Conference Call on Wednesday, July 27, 2016 - [GlobeNewswire] - NASHUA, N.H., July 14, 2016-- iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced ...
07/07/16 04:38 PMiCAD : First Cervical Cancer Patient Treated in Europe with the Xoft System at Hospital Universitario Miguel Servet in Spain
07/02/16 07:28 AMNon-Melanoma Skin Cancer Market : Growth, Development, and Outlook 2015 to 2021
06/28/16 07:40 AMFirst Cervical Cancer Patient Treated in Europe with the Xoft System at Hospital Universitario Miguel Servet in Spain - [PR Newswire] - NASHUA, N.H. and ZARAGOZA, Spain, June 28, 2016 /PRNewswire/ -- iCAD, Inc. (ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced the first cervical cancer patient in Europe was treated with the Xoft® Axxent® Electronic Brachytherapy (eBx®) System® at the Hospital Universitario Miguel Servet in Zaragoza, Spain in May 2016. "International adoption of the Xoft System has increased significantly in recent years, further demonstrating our commitment to providing global access to electronic brachytherapy for patients who may benefit from iCAD's revolutionary technology," said Ken Ferry, CEO of iCAD.
06/23/16 07:29 AMiCAD commends final USPSTF recommendations supporting CT colonography for colorectal cancer screening
06/23/16 07:29 AMiCAD commends final USPSTF recommendations for colorectal cancer screening
06/22/16 10:09 AMJune 21, 2016 iCAD Commends Final USPSTF Recommendations For Colorectal Cancer Screening Including Computed Tomography Colonography (CTC) - [at noodls] - NASHUA, N.H. (June 21, 2016) - iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of ...
06/22/16 09:15 AMGlobal Medical Automation Market Size, Share, Trends, Growth and Forecast 2021 - Acute Market Reports
06/22/16 09:15 AMiCAD Commends Ultimate USPSTF Recommendations for Colorectal Cancer Screening Together with Computed Tomography Colonography (CTC). South Carolina SC
06/21/16 11:04 AM12:04 pm iCAD announces support of new USPSTF recommendations for colorectal cancer screening that include use of computed tomography colonography -
06/21/16 11:02 AMiCAD Commends Final USPSTF Recommendations for Colorectal Cancer Screening Including Computed Tomography Colonography (CTC) - [PR Newswire] - NASHUA, N.H., June 21, 2016 /PRNewswire/ -- iCAD (ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced its support for the new U.S. Preventive Services Task Force (USPSTF) recommendations for colorectal cancer (CRC) screening that include use of computed tomography colonography (CTC). The Affordable Care Act requires private insurers to fully cover all USPSTF-recognized CRC screening exams, for adults aged 50 to 75 years old, including screenings with CTC technology. "We applaud the USPSTF for recognizing CTC as an effective cancer screening tool and hope that this will encourage people of screening age to opt for the exam, which is less invasive and does not require sedation," said Ken Ferry, CEO of iCAD.
06/04/16 04:32 PMResearch report explores the radiation therapy in oncology drug consumption market research report: global analysis 2016-2021
06/03/16 10:05 AMiCAD to Present at the 6th Annual LD Micro Invitational - [at noodls] - NASHUA, N.H. (June 3, 2016) - iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of ...
06/03/16 08:00 AMiCAD To Present At The LD Micro Invitational - [Accesswire] - NASHUA, NH / ACCESSWIRE / June 3, 2016 / iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment ...
05/30/16 06:06 PMPerformance at a Glance on iCAD, Inc. (NASDAQ:ICAD) - HNN - Performance at a Glance on iCAD, Inc. (NASDAQ:ICAD)HNNWhen speculating how a given stock will perform in the future, it is important to look at how it has performed in the past. Today we will examine how iCAD, Inc. (NASDAQ:ICAD)'s stock has performed at various points in its past. Currently, the stock ...and more »
05/25/16 09:06 AMiCAD to Participate in the 13th Annual Craig-Hallum Institutional Investor Conference Read More - [at noodls] - iCAD to Participate in the 13th Annual Craig-Hallum Institutional Investor Conference NASHUA, NH- (May 25, 2016) - iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow ...
05/25/16 08:00 AMiCAD to Participate in the 13th Annual Craig-Hallum Institutional Investor Conference - [GlobeNewswire] - NASHUA, N.H., May 25, 2016--. iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced ...
05/23/16 08:36 AMiCAD Announces Increased Adoption Of iReveal® Automated Breast Density Solution In U.S. - [at noodls] - iCAD Announces Increased Adoption Of iReveal® Automated Breast Density Solution In U.S. ... This is an abstract of the original noodl. To continue reading this document, click here for the original version....
05/11/16 10:52 AMiCAD, Inc. :ICAD-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/10/16 05:23 PMICAD INC Files SEC form 10-Q, Quarterly Report -
05/06/16 02:25 PMICAD INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
05/05/16 10:00 AMICAD: Look For Turnaround in NMSC, Tomo Launch - [Zacks Small Cap Research] - By Brian Marckx, CFA NASDAQ:ICAD Q1 2016 Results: Revenue Disappoints. Continue To Look For Tomo Launch, NMSC Reimbursement Improvement… iCAD (NASDAQ:ICAD) announced financial results for the first quarter ...
05/03/16 07:00 PMiCAD Reports First Quarter 2016 Financial Results - [at noodls] - For Immediate Release iCAD REPORTS FIRST QUARTER 2016 FINANCIAL RESULTS Reports Progress with Reimbursement Under New CPT 3 Code for the Treatment of Non- melanoma Skin Cancer with Electronic Brachytherapy ...
05/03/16 06:07 AMQ1 2016 ICAD Inc Earnings Release - After Market Close -
04/22/16 02:41 AMApril 21, 2016 iCAD to Host First Quarter 2016 Financial Results Conference Call on Tuesday, May 3, 2016 - [at noodls] - iCAD to Host First Quarter 2016 Financial Results Conference Call on Tuesday, May 3, 2016 NASHUA, NH (April 21, 2016)- iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, ...
04/21/16 03:00 PMiCAD to Host First Quarter 2016 Financial Results Conference Call on Tuesday, May 3, 2016 - [GlobeNewswire] - NASHUA, N.H., April 21, 2016-- iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today ...
04/12/16 02:00 PMiCAD announces CAD system for Fujifilm's Aspire Cristalle full-field digital mammography - NASHUA, NH, 8 April 2016 – iCAD, Inc., (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the identification and treatment of cancer, today announced that its mammography Computer Aided ...
04/11/16 02:03 PMiCAD Launches Computer-Aided Detection Solution For Full Field Digital Mammography - iCAD Inc (NASDAQ: ICAD) unveiled its mammography Computer Aided Detection (CAD) solution and is available on Fujifilm's Aspire Cristalle full field digital mammography system. iCAD's Director for marketing Cancer detection solutions, Diane Clifford, said, "iCAD is pleased to provide our leading mammography CAD solution to Fujifilm's Aspire Cristalle customers worldwide. We trust our integrated solutions will now provide radiologists ...Full story available on Benzinga.com
04/11/16 11:47 AMiCAD Announces Computer Aided Detection Solution for Fujifilm’s Aspire Cristalle Full Field Digital Mammography - [Business Wire] - iCAD, Inc., , an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the identification and treatment of cancer, today announced that its mammography Computer Aided Detection solution is now available on Fujifilm’s Aspire Cristalle full field digital mammography system.
03/11/16 03:15 PMICAD INC Files SEC form 10-K, Annual Report -
03/09/16 11:00 AMiCAD, Inc. :ICAD-US: Earnings Analysis: 2015 By the Numbers -
03/09/16 08:00 AMiCAD to Present at the 28th Annual ROTH Conference - [GlobeNewswire] - NASHUA, N.H., March 09, 2016-- iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today ...
03/04/16 07:00 AMiCAD Showcases Latest Technology Supporting Use of Xoft System for Non-melanoma Skin Cancer Treatment at AAD 2016 - [PR Newswire] - NASHUA, N.H. and WASHINGTON, March 4, 2016 /PRNewswire/ -- iCAD, Inc. (ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, is unveiling a new Streamlined Module for Advanced Radiation Therapy (SMART) solution for its Xoft® Axxent® Electronic Brachytherapy (eBx®) System® and Axxent Hub cloud-based oncology collaboration software solution, along with a new extended-life X-ray source, during the American Academy of Dermatology (AAD) Annual Meeting in Washington, D.C. from March 4-8, 2016 (Booth #2465). Comprised of a new Wi-Fi enabled Xoft System and enhanced Axxent Hub cloud software, the SMART solution improves workflow efficiency and the flexibility and security of skin eBx treatments while improving clinical collaboration and supervision.
03/03/16 10:00 AMICAD: Look For Pick Up in 2016 With Tomo Contribution - [Zacks Small Cap Research] - Then, as expected, a dedicated non-melanoma skin cancer code (CPT III code 0394T) went into effect on Jan 1, 2016. While the hope was that this would clear up at least some ambiguity relative to what providers could expect in terms of payment, given that the code is “carrier priced” (i.e.
03/02/16 02:33 PMICAD INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits -
03/02/16 07:00 AMiCAD Announces Breakthrough Technology For Use With Digital Breast Tomosynthesis Exams At The European Congress Of Radiology - [PR Newswire] - NASHUA, N.H. and VIENNA, March 2, 2016 /PRNewswire/ -- iCAD, Inc. (ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, announced today an industry first tomosynthesis Computer-Aided Detection (CAD) solution and workflow tool. The technology will be introduced in Europe and will be available for demonstration in the iCAD booth (Expo X1, Booth # 554- lower level) during the European Congress of Radiology (ECR) meeting, from March 2-6, 2016 in Vienna, Austria. This is the latest innovative solution available with iCAD's PowerLook Advanced Mammography Platform (AMP).
03/01/16 03:01 PMiCAD Reports Fourth Quarter and Full Year 2015 Financial Results - [GlobeNewswire] - NASHUA, N.H., March 01, 2016-- iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today ...
03/01/16 06:07 AMQ4 2015 ICAD Inc Earnings Release - After Market Close -
02/26/16 08:11 AMICAD, INC. Company Profile - Early detection is the best prevention in iCAD's eyes. The company targets the breast cancer detection market with its core SecondLook computer-aided detection (CAD) systems. The systems include workstations and analytical software that help radiologists ...
02/12/16 12:19 PMXoft Single-Dose Radiation Therapy for Early-Stage Breast Cancer Shows Continuing Promise - iCAD Inc., a company that delivers innovative cancer detection and radiation therapy solutions, recently presented updated clinical data on the use of intraoperative radiation therapy (IORT) with the Company’s Xoft Axxent Electronic Brachytherapy System ...
02/02/16 08:00 AMiCAD to Host Fourth Quarter and Full Year 2015 Financial Results Conference Call on Tuesday, March 1, 2016 - [GlobeNewswire] - NASHUA, N.H., Feb. 02, 2016-- iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced ...
01/29/16 10:50 AMMedical Automation Market Analysis, Size, Share, Growth To 2020: Grand View Research, Inc. - Inc., Icad, Inc., Omron Corporation and Holding AG. Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports ...
01/16/16 06:30 PMGlobal Computer Aided Detection Market to Rise to US$1.47 Bn by 2020 Due to Growing Prevalence of Cancer - Inc., Agfa-Gevaert N.V., iCAD, Inc., and Hologic, Inc. Key segments of the Global Computer Aided Detection Market Rest of the World
12/08/15 07:00 AMResearchers to Present Updated Data Regarding Intraoperative Radiation Therapy with the Xoft System at San Antonio Breast Cancer Symposium - [PR Newswire] - NASHUA, N.H. and SAN ANTONIO, Dec. 8, 2015 /PRNewswire/ -- iCAD, Inc. (ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced that researchers will present updated data on the use of intraoperative radiation therapy (IORT) with the Xoft® Axxent® Electronic Brachytherapy (eBx®) System® for the treatment of early-stage breast cancer during the San Antonio Breast Cancer Symposium (SABCS) at the Henry B. Gonzalez Convention Center in San Antonio, Texas. The company also announced that more than 2,000 early-stage breast cancer patients have been treated to-date with IORT with the Xoft System. The Xoft System and its suite of products will be showcased at SABCS in the Xoft booth (#345) throughout the meeting from December 9-11.
11/30/15 07:00 AMiCAD Featuring New Technology for Automated Breast Density Assessment and Showcasing Solutions for Tomosynthesis at RSNA 2015 - [PR Newswire] - NASHUA, N.H., Nov. 30, 2015 /PRNewswire/ -- iCAD, Inc. (ICAD) announced today that it will feature its latest solutions for advanced image analysis and workflow tools for the early identification of cancer at the Radiological Society of North American (RSNA) 2015 Annual Meeting in Chicago from November 29 to December 4, 2015. The iReveal® automated breast density solution is designed to standardize the assessment and reporting of breast density. iReveal assists radiologists in evaluating and scoring breast density to identify patients who may be at higher risk of developing breast cancer.
11/23/15 08:00 AMiCAD To Present At The LD Micro "Main Event" Microcap Conference - [Accesswire] - NASHUA, NH / ACCESSWIRE / November 23, 2015 / iCAD, Inc. (NASDAQ: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and ...
11/23/15 07:00 AMiCAD Reports Use Of Xoft® Axxent® Electronic Brachytherapy System In The Treatment Of More Than 15,000 Non-Melanoma Skin Cancer Lesions - [PR Newswire] - NASHUA, N.H., Nov. 23, 2015 /PRNewswire/ -- iCAD, Inc. (ICAD), an industry leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced that the company's Xoft® Axxent® Electronic Brachytherapy (eBx®) System has been used in the treatment of more than 15,000 non-melanoma skin cancer (NMSC) lesions. An analysis of the 7,000 lesions collected through the Xoft System's Axxent Hub cloud-based software shows that the average age of patients treated is 74.9 years, indicating that clinicians are treating an age-appropriate group of patients for whom this technology represents an advantageous treatment option. "NMSC continues to be a global health problem and is now the most common type of cancer diagnosed in the United States with an estimated 3.5 million new cases each year.i Based on the available and expanding body of literature demonstrating that this therapy is safe and effective for appropriate patients, we are working to make sure that both patients and clinicians have the comprehensive and accurate information they need about the benefits of eBx," said Ken Ferry, CEO of iCAD.

Social

About Icad inc.

iCAD, Inc. is a provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer. The Company provides image analysis and clinical decision support solutions for mammography, Magnetic Resonance Imaging and Computed Tomography imaging. It operates in two segments: Cancer Detection (Detection) and Cancer Therapy (Therapy). The Detection segment consists of its advanced image analysis and workflow products, and the Therapy segment consists of its radiation therapy products. The Company sells its products through its direct sales organization, as well as through various original equipment manufacturer partners, distributors and resellers. It develops and markets computer-aided detection (CAD) solutions for digital and film-based mammography systems. Its Axxent SPX Controller includes an optimized skin treatment arm customized for compatibility in confined patient treatment rooms in physician office-based facilities.

Industry, Sector and Symbol:
  • Sector: Computer and Technology
  • Industry: Technical & System Software
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ICAD
  • CUSIP:
Key Metrics:
  • Previous Close: $4.70
  • 50 Day Moving Average: $5.04
  • 200 Day Moving Average: $4.85
  • P/E Ratio: N/A
  • P/E Growth: -0.75
  • Market Cap: $72.96M
  • Beta: 1.99
  • Current Year EPS Consensus Estimate: $-0.44 EPS
  • Next Year EPS Consensus Estimate: $-0.06 EPS
Additional Links:
Icad inc. (NASDAQ:ICAD) Chart for Wednesday, July, 27, 2016